Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Sernova Biotherapeutics Inc

Market Cap 58.44M 41.74M 36.12M 33.25M 31.16M 3.97B 59.34M 394M 153M 1.93B 157M 153M 6.69B P/E Ratio 2026 *
-4.83x
P/E Ratio 2027 * -3.63x
Enterprise Value 58.44M 41.74M 36.12M 33.25M 31.16M 3.97B 59.34M 394M 153M 1.93B 157M 153M 6.69B EV / Sales 2026 *
-
EV / Sales 2027 * 11.7x
Free-Float
86.83%
Yield 2026 *
-
Yield 2027 * -
1 day-6.45%
1 week-6.45%
Current month+3.57%
1 month-9.38%
3 months-14.71%
6 months+7.41%
Current year+11.54%
1 week 0.14
Extreme 0.14
0.16
1 month 0.14
Extreme 0.135
0.17
Current year 0.12
Extreme 0.125
0.2
1 year 0.12
Extreme 0.12
0.21
3 years 0.12
Extreme 0.12
1.1
5 years 0.12
Extreme 0.12
2.22
10 years 0.1
Extreme 0.095
2.87
Manager TitleAgeSince
Chief Executive Officer 58 12/08/2024
Director of Finance/CFO 60 11/10/2024
Investor Relations Contact - 11/10/2024
Director TitleAgeSince
Director/Board Member 60 19/04/2012
Director/Board Member - 24/04/2023
Director/Board Member - 01/09/2024
Date Insider Type Main position Quantity % Market Cap.
05-22Option

Director

260,000 0.0748%
05-22Option

Director

194,229 0.0559%
05-22Option

Director

260,000 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
-6.45%-6.45%-12.12%-83.33% 41.73M
+2.15%+3.65%-18.07%+11.25% 117B
-0.31%+0.04%+1.12%-5.11% 12.86B
+2.05%+4.21%+27.90%+88.29% 7.29B
+1.87%-3.51%-46.74%-69.06% 4.12B
+2.06%+5.59%+11.04%+33.01% 2.49B
+5.46%+10.30%-16.96%-14.78% 1.7B
+1.67%-6.39%+3.63%-11.43% 1.63B
-8.89%-8.45%+165.17%+112.14% 1.49B
Average -0.04%+0.58%+12.77%+6.77% 16.53B
Weighted average by Cap. +1.84%+1.38%-12.38%+12.19%

Financials

2026 *2027 *
Net sales - 5M 3.57M 3.09M 2.85M 2.67M 340M 5.08M 33.75M 13.09M 165M 13.42M 13.13M 573M
Net income -12.83M -9.16M -7.93M -7.3M -6.84M -872M -13.03M -86.58M -33.57M -424M -34.42M -33.68M -1.47B -19.77M -14.12M -12.22M -11.25M -10.54M -1.34B -20.08M -133M -51.75M -654M -53.05M -51.92M -2.26B
Net Debt - -
Logo Sernova Biotherapeutics Inc
Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
Employees
8
Date Price Change Volume
12/06/26 0.1450 $ -6.45% 129,330
11/06/26 0.1550 $ +3.33% 207,625
10/06/26 0.1500 $ 0.00% 6,300
09/06/26 0.1500 $ 0.00% 46,335
08/06/26 0.1500 $ 0.00% 49,500
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1450CAD
Average target price
0.4500CAD
Spread / Average Target
+210.34%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!